iCAD, Inc. (ICAD) - Return on Sales by Net Profit

Corporate emblem and logo of icadmed.com (ICAD)

Net profit margin reflects the automation dynamics of mammogram analysis via AI platforms. High computer vision accuracy in early pathology detection and the B2B integration of ProFound software into oncology centers ensure business stability. Meanwhile, the -26.80 level captures the latest sales margin figures, allowing for a real-time assessment of iCAD, Inc. (ICAD) efficiency relative to industry yield standards.

iCAD (ICAD) - Company Sales Margin from 07/04/2022 to 08/02/2025

Analytical breakdowns and data insights for company iCAD Inc. (ICAD)

- share price and expert price forecast:
Analysis of all company metrics:iCAD - ICAD
Flagship merchandise of iCAD

Investors are attracted to the resilience of iCAD, Inc. (ICAD) against market volatility. Net margin measures the portion of profit remaining after all expenses are deducted from revenue, determining the efficiency of converting sales into capital. By analyzing the profit margin ratio, one can assess the business's ability to generate cash flow. Strong pricing power in the AI breast cancer diagnostics segment supports this metric. The fundamental growth of this metric confirms the uniqueness of the ProFound AI platform.

Competitors of iCAD, Inc. (ICAD)

ONC: Net Sales Margin|Net Margin Halozyme Inc. (HALO)|Net Margin RevMed|Net Return on Sales AAPG (Ascentage Pharma Group)|Net Sales Margin CGON|UroGen Pharma - Net Return on Sales|Bicara Therapeutics - Return on Sales by Net Profit|Net Sales Margin Personalis Inc PSNL|Erasca Oncology - Net Sales Margin|Net Profit Rate DCTH (Delcath Corp)|YMAB: Net Sales Margin|AURA - Company Sales Margin|CADL (Candel Therapeutics Inc.) - Net Sales Margin|Net Return on Sales ARAY (Accuray)|Return on Sales by Net Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Net Margin|Net Margin Citius Oncology, Inc. CTOR|HURA - Return on Sales by Net Profit|protaratx.com - Net Sales Margin|FATE - Net Sales Margin|WHWK: Net Sales Margin|TScan Therapeutics (TCRX) - Net Sales Margin|Net Margin Champions Oncology|Net Margin XBIT|Net Sales Margin CVM|Return on Sales by Net Profit OS Therapies Inc. OSTX|Net Margin Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Net Margin|ANL - Net Margin|Net Margin verupharma.com|TPST: Net Sales Margin|XLO - Company Sales Margin|Net Margin Renovaro|Net Sales Margin muraloncology.com|Net Sales Margin KAPA|Company Sales Margin OnKure Therapeutics, Inc.|Net Sales Margin GDTC (w2.cytomed.sg)|CRIS - Return on Sales by Net Profit|Apollomics - Net Sales Margin|Tharimmune Corp (THAR) - Return on Sales by Net Profit|ADVB: Net Sales Margin|Return on Sales by Net Profit Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Net Sales Margin|Net Return on Sales SBFM (Sunshine Biopharma)|Net Margin Xenetic Bio (XBIO)|Net Margin SLRX (Salarius Pharma)|Kitov Pharma - Return on Sales by Net Profit|American Oncology Network (AONC) - Net Margin|BeiGene - Net Sales Margin|Checkpoint Therapeutics, Inc. (CKPT) - Return on Sales by Net Profit|ELEV (Elevation Oncology, Inc.) - Return on Sales by Net Profit|Ikena Oncology, Inc. - Net Profit Rate|Return on Sales by Net Profit NTBL|VIRX: Net Profit Rate|Net Margin MorphoSys Corporation (MOR)|NAYA - Net Margin|Net Sales Margin AAPGV (Ascentage)